Itau Unibanco Holding S.A. Immunity Bio, Inc. Transaction History

Itau Unibanco Holding S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.68 - $6.14 $4,799 - $10,996	1,791 Added 22.55%	9,734 $36,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $21,988 - $39,478	3,878 Added 95.4%	7,943 $51,000
Q3 2021 Nov 12, 2021	BUY	$9.17 - $14.24 $12,782 - $19,850	1,394 Added 52.19%	4,065 $40,000
Q2 2021 Aug 17, 2021	BUY	$13.41 - $22.4 $35,818 - $59,830	2,671 New	2,671 $38,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.